GLP-1, Chronic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
Since kidney disease often progresses without noticeable symptoms in the early stages, its important to stay vigilant and ...
Duncan, who has chronic kidney disease, has worked with dance companies in Chicago and around the world over his decades-long ...
When Mrs Jennie Tan was diagnosed with end-stage kidney disease, her husband made a decision that gave her a second chance at ...
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
Chronic health conditions are having a serious, negative impact on the welfare of the country's workers and their output, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results